BioCatalystWatch
ANROWorkspace / ANRO / OverviewCompany library
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (ANRO)

Website

Price
Market cap
Next catalystExpected 1H 2027ALTO-300 · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

ALTO-100

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

ALTO-300

Small molecule

Melatonin MT1 receptor × Melatonin MT2 receptor × 5-HT2C receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

Upcoming / outlook

  • Timing and evidence

ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

Upcoming / outlook

ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ALTO-300

Small molecule

Melatonin MT1 receptor × Melatonin MT2 receptor × 5-HT2C receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

Upcoming / outlook

  • Timing and evidence

ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

Upcoming / outlook

ALTO-100

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

Upcoming / outlook

Other pipelines

ALTO-100

Small molecule

PreINDP1P2P3FilingApproved
ALTO-207

Dopamine D3 receptor × Dopamine D2 receptor × 5-HT3 receptor

PreINDP1P2P3FilingApproved
ALTO-203

Small molecule

Histamine H3 receptor

PreINDP1P2P3FilingApproved
ALTO-202

Small molecule

NMDA receptor GluN2B

PreINDP1P2P3FilingApproved
ALTO-202

Small molecule

NMDA receptor GluN2B

PreINDP1P2P3FilingApproved
ALTO-208

NK-1 receptor

PreINDP1P2P3FilingApproved

History / paused

ALTO-100

Small molecule

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ANRO PR & News

PR & News

ANRO SEC archive